- Exchange: Tokyo
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
CanBas Co Ltd+ Add to Watchlist
4575:JP1,260.0 JPY 55.0 4.18%
As of 01:00:00 ET on 11/27/2014.
Company Profile for CanBas Co Ltd (4575)
CanBas Company Ltd. is a biopharmaceutical company that develops anti-cancer drugs with fewer side effects. The Company's core technologies include drugs that target the G2 checkpoint and a screening system to find selective abrogators of the G2 checkpoint.
CanBas Co Ltd
Key Executives for CanBas Co Ltd (4575)
|Takumi KawabePresident||Makoto KatozumiDirector/CFO|